RAYNHAM, Mass., May 14, 2018 /PRNewswire/ — OMNIlife science, Inc. (“OMNI”), a privately-held, established medical technology company targeting the $15 billion global hip and knee replacement device market, reported today that Rick Epstein has joined OMNI as CEO.  Before joining OMNI, Mr. Epstein served as President and CEO of Sonoma Orthopedic Products for 5 years. Prior to Sonoma, Rick held several executive […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone